Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arsenic | 5 | 2023 | 356 | 1.680 |
Why?
|
Neural Stem Cells | 4 | 2023 | 898 | 1.270 |
Why?
|
Asthma | 17 | 2023 | 6270 | 1.220 |
Why?
|
Bronchi | 5 | 2021 | 843 | 1.180 |
Why?
|
MicroRNAs | 12 | 2022 | 3785 | 1.090 |
Why?
|
Arsenic Poisoning | 2 | 2023 | 55 | 1.030 |
Why?
|
Receptors, Adrenergic, beta-2 | 4 | 2020 | 216 | 0.970 |
Why?
|
Flavoring Agents | 3 | 2021 | 54 | 0.930 |
Why?
|
Arrestins | 2 | 2018 | 73 | 0.920 |
Why?
|
Epithelial Cells | 4 | 2021 | 3681 | 0.860 |
Why?
|
Respiratory Hypersensitivity | 1 | 2023 | 271 | 0.730 |
Why?
|
Gene Expression Regulation | 10 | 2021 | 11888 | 0.700 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 2 | 2012 | 146 | 0.670 |
Why?
|
Smoke | 1 | 2021 | 243 | 0.650 |
Why?
|
Diacetyl | 1 | 2019 | 21 | 0.640 |
Why?
|
Ribosomal Proteins | 1 | 2021 | 366 | 0.640 |
Why?
|
Lead | 3 | 2023 | 879 | 0.590 |
Why?
|
Hypersensitivity | 2 | 2024 | 1168 | 0.550 |
Why?
|
Flavonoids | 1 | 2020 | 448 | 0.550 |
Why?
|
Muscle, Smooth | 4 | 2022 | 931 | 0.550 |
Why?
|
Arrestin | 2 | 2017 | 30 | 0.540 |
Why?
|
Cytoskeleton | 2 | 2019 | 1178 | 0.540 |
Why?
|
Anti-Inflammatory Agents | 2 | 2017 | 1808 | 0.520 |
Why?
|
Myocytes, Smooth Muscle | 5 | 2022 | 702 | 0.510 |
Why?
|
RNA Interference | 5 | 2020 | 2832 | 0.510 |
Why?
|
Cell Membrane | 2 | 2017 | 3634 | 0.490 |
Why?
|
Hazardous Substances | 1 | 2016 | 153 | 0.490 |
Why?
|
Allergens | 1 | 2023 | 1436 | 0.490 |
Why?
|
Influenza Vaccines | 1 | 2023 | 778 | 0.490 |
Why?
|
Receptors, Glucocorticoid | 1 | 2017 | 308 | 0.490 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2016 | 190 | 0.490 |
Why?
|
Amides | 1 | 2017 | 455 | 0.470 |
Why?
|
Cilia | 1 | 2019 | 499 | 0.470 |
Why?
|
Protein Biosynthesis | 1 | 2021 | 2086 | 0.450 |
Why?
|
Lung | 7 | 2023 | 10033 | 0.450 |
Why?
|
Drug Carriers | 1 | 2018 | 700 | 0.430 |
Why?
|
HEK293 Cells | 6 | 2020 | 4260 | 0.420 |
Why?
|
Thiophenes | 1 | 2017 | 569 | 0.420 |
Why?
|
Interferon Regulatory Factors | 1 | 2014 | 271 | 0.410 |
Why?
|
Receptors, Notch | 1 | 2017 | 752 | 0.410 |
Why?
|
Geranyltranstransferase | 1 | 2012 | 5 | 0.400 |
Why?
|
Amino Acid Transport System A | 1 | 2012 | 5 | 0.400 |
Why?
|
Glucocorticoids | 2 | 2022 | 2132 | 0.400 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2017 | 1333 | 0.390 |
Why?
|
Influenza, Human | 1 | 2023 | 1539 | 0.380 |
Why?
|
Transport Vesicles | 1 | 2012 | 79 | 0.370 |
Why?
|
Expressed Sequence Tags | 1 | 2012 | 251 | 0.370 |
Why?
|
Dexamethasone | 3 | 2018 | 1963 | 0.370 |
Why?
|
Down-Regulation | 4 | 2020 | 2927 | 0.340 |
Why?
|
Apoptosis | 3 | 2020 | 9514 | 0.320 |
Why?
|
Neoplasm Proteins | 2 | 2018 | 3596 | 0.310 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2017 | 1892 | 0.300 |
Why?
|
Cell Adhesion Molecules | 1 | 2014 | 1612 | 0.290 |
Why?
|
Alendronate | 2 | 2019 | 174 | 0.290 |
Why?
|
Hippocampus | 1 | 2020 | 3775 | 0.290 |
Why?
|
Endocytosis | 1 | 2012 | 951 | 0.280 |
Why?
|
Adrenal Cortex Hormones | 3 | 2020 | 1880 | 0.250 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2016 | 2878 | 0.250 |
Why?
|
Receptor, Notch2 | 2 | 2017 | 90 | 0.240 |
Why?
|
Budesonide | 3 | 2022 | 163 | 0.240 |
Why?
|
Anti-Asthmatic Agents | 2 | 2020 | 572 | 0.220 |
Why?
|
Neurons | 2 | 2020 | 9525 | 0.220 |
Why?
|
Cell Line | 6 | 2018 | 15543 | 0.220 |
Why?
|
Environmental Pollutants | 2 | 2017 | 1290 | 0.210 |
Why?
|
Phosphate-Binding Proteins | 1 | 2024 | 93 | 0.210 |
Why?
|
Receptor, Cholecystokinin A | 1 | 2023 | 13 | 0.210 |
Why?
|
Cell Differentiation | 1 | 2020 | 11641 | 0.200 |
Why?
|
Antipyretics | 1 | 2022 | 22 | 0.200 |
Why?
|
Cholecystokinin | 1 | 2023 | 114 | 0.200 |
Why?
|
Particulate Matter | 3 | 2021 | 2624 | 0.200 |
Why?
|
Muscle Contraction | 2 | 2018 | 1206 | 0.200 |
Why?
|
Mice, Obese | 1 | 2023 | 417 | 0.190 |
Why?
|
Humans | 50 | 2024 | 765968 | 0.190 |
Why?
|
Administration, Inhalation | 4 | 2020 | 1154 | 0.190 |
Why?
|
Connexins | 1 | 2023 | 356 | 0.190 |
Why?
|
Proline | 1 | 2023 | 453 | 0.180 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5696 | 0.180 |
Why?
|
Signal Transduction | 7 | 2020 | 23601 | 0.180 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2023 | 385 | 0.180 |
Why?
|
Gene Expression Profiling | 6 | 2021 | 9525 | 0.180 |
Why?
|
Genome-Wide Association Study | 9 | 2019 | 12807 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2020 | 2453 | 0.170 |
Why?
|
Genomics | 2 | 2016 | 5929 | 0.170 |
Why?
|
Caspases | 1 | 2023 | 880 | 0.170 |
Why?
|
Genes, Suppressor | 1 | 2019 | 47 | 0.160 |
Why?
|
Transcription Factor CHOP | 1 | 2019 | 69 | 0.160 |
Why?
|
Animals | 12 | 2024 | 168764 | 0.160 |
Why?
|
Protein Transport | 2 | 2017 | 1939 | 0.160 |
Why?
|
Gelsolin | 1 | 2019 | 189 | 0.160 |
Why?
|
Inhalation Exposure | 2 | 2019 | 432 | 0.150 |
Why?
|
Antigens, Viral | 1 | 2023 | 995 | 0.150 |
Why?
|
Genetic Loci | 3 | 2018 | 2631 | 0.150 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2016 | 3797 | 0.150 |
Why?
|
Pneumonia, Pneumococcal | 1 | 2019 | 133 | 0.150 |
Why?
|
Cofilin 1 | 1 | 2018 | 14 | 0.150 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2019 | 2942 | 0.150 |
Why?
|
Cells, Cultured | 6 | 2020 | 18973 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 7 | 2019 | 18071 | 0.140 |
Why?
|
Polymorphism, Single Nucleotide | 9 | 2018 | 16047 | 0.140 |
Why?
|
Antigens | 1 | 2023 | 1438 | 0.140 |
Why?
|
Methacholine Chloride | 1 | 2017 | 220 | 0.140 |
Why?
|
Unfolded Protein Response | 1 | 2019 | 239 | 0.140 |
Why?
|
Hyperinsulinism | 1 | 2020 | 402 | 0.130 |
Why?
|
Aldehydes | 1 | 2017 | 168 | 0.130 |
Why?
|
Ubiquitination | 2 | 2012 | 996 | 0.130 |
Why?
|
HIV Infections | 1 | 2023 | 17533 | 0.130 |
Why?
|
Gene Knockout Techniques | 1 | 2019 | 798 | 0.130 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2016 | 857 | 0.130 |
Why?
|
Recombinant Fusion Proteins | 2 | 2018 | 3737 | 0.130 |
Why?
|
Formaldehyde | 1 | 2017 | 352 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-cbl | 1 | 2016 | 120 | 0.130 |
Why?
|
Pyroglyphidae | 1 | 2016 | 94 | 0.130 |
Why?
|
Child | 12 | 2023 | 80564 | 0.120 |
Why?
|
Drug Repositioning | 1 | 2017 | 246 | 0.120 |
Why?
|
Occupational Health | 1 | 2021 | 813 | 0.120 |
Why?
|
DNA-Binding Proteins | 1 | 2012 | 9601 | 0.120 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2020 | 722 | 0.120 |
Why?
|
Osteopontin | 1 | 2016 | 304 | 0.120 |
Why?
|
Respiratory System | 1 | 2018 | 559 | 0.110 |
Why?
|
Respiratory Insufficiency | 1 | 2022 | 1240 | 0.110 |
Why?
|
Camptothecin | 1 | 2017 | 600 | 0.110 |
Why?
|
Water Pollution, Chemical | 1 | 2013 | 30 | 0.110 |
Why?
|
Bronchodilator Agents | 2 | 2019 | 514 | 0.110 |
Why?
|
Cell Proliferation | 3 | 2020 | 10429 | 0.110 |
Why?
|
Environmental Exposure | 3 | 2020 | 4544 | 0.110 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2017 | 618 | 0.110 |
Why?
|
Mice | 6 | 2023 | 81819 | 0.110 |
Why?
|
Drug Synergism | 1 | 2017 | 1749 | 0.110 |
Why?
|
Endoplasmic Reticulum | 1 | 2019 | 1132 | 0.110 |
Why?
|
Water Pollutants, Chemical | 2 | 2013 | 358 | 0.100 |
Why?
|
Genome, Human | 2 | 2018 | 4448 | 0.100 |
Why?
|
Green Fluorescent Proteins | 1 | 2018 | 2060 | 0.100 |
Why?
|
Transcription Factors | 1 | 2012 | 12131 | 0.100 |
Why?
|
Estrogen Receptor alpha | 1 | 2016 | 578 | 0.100 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2020 | 3247 | 0.100 |
Why?
|
Virus Release | 1 | 2012 | 35 | 0.100 |
Why?
|
Chemokines | 1 | 2016 | 956 | 0.100 |
Why?
|
Arsenites | 1 | 2012 | 64 | 0.100 |
Why?
|
Exons | 1 | 2018 | 2391 | 0.100 |
Why?
|
Small Molecule Libraries | 1 | 2017 | 741 | 0.100 |
Why?
|
NF-kappa B | 2 | 2017 | 2485 | 0.100 |
Why?
|
Cognition | 2 | 2020 | 7049 | 0.090 |
Why?
|
High-Throughput Screening Assays | 1 | 2017 | 938 | 0.090 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 1 | 2012 | 109 | 0.090 |
Why?
|
Francisella tularensis | 1 | 2012 | 60 | 0.090 |
Why?
|
Activating Transcription Factor 4 | 1 | 2012 | 86 | 0.090 |
Why?
|
Gene Library | 1 | 2014 | 1067 | 0.090 |
Why?
|
Fibroblasts | 2 | 2019 | 4159 | 0.090 |
Why?
|
Up-Regulation | 2 | 2016 | 4137 | 0.090 |
Why?
|
Cell Survival | 1 | 2020 | 5747 | 0.090 |
Why?
|
Obesity | 3 | 2023 | 13076 | 0.090 |
Why?
|
Membrane Fusion | 1 | 2012 | 264 | 0.090 |
Why?
|
Immunologic Factors | 1 | 2019 | 1587 | 0.090 |
Why?
|
Bangladesh | 3 | 2018 | 745 | 0.090 |
Why?
|
Forced Expiratory Volume | 3 | 2020 | 1828 | 0.080 |
Why?
|
Extracellular Space | 1 | 2012 | 563 | 0.080 |
Why?
|
Polymorphism, Genetic | 1 | 2020 | 4247 | 0.080 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 904 | 0.080 |
Why?
|
Amino Acid Sequence | 2 | 2012 | 13400 | 0.080 |
Why?
|
Amino Acid Motifs | 1 | 2012 | 924 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 1 | 2020 | 8102 | 0.080 |
Why?
|
Molecular Sequence Data | 2 | 2012 | 17594 | 0.080 |
Why?
|
RNA | 1 | 2018 | 2717 | 0.070 |
Why?
|
Receptors, Cell Surface | 1 | 2017 | 2817 | 0.070 |
Why?
|
Male | 22 | 2020 | 363698 | 0.070 |
Why?
|
Adenosine Triphosphatases | 1 | 2012 | 837 | 0.070 |
Why?
|
DNA Primers | 1 | 2012 | 2825 | 0.070 |
Why?
|
Exosomes | 1 | 2012 | 421 | 0.070 |
Why?
|
Cell Movement | 1 | 2019 | 5194 | 0.070 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2019 | 2176 | 0.070 |
Why?
|
Sequence Analysis, RNA | 1 | 2014 | 2034 | 0.070 |
Why?
|
RNA, Small Interfering | 2 | 2018 | 3421 | 0.060 |
Why?
|
Sequence Alignment | 1 | 2010 | 2171 | 0.060 |
Why?
|
Immunity | 1 | 2012 | 1002 | 0.060 |
Why?
|
Risk | 1 | 2018 | 9591 | 0.060 |
Why?
|
Gene Knockdown Techniques | 1 | 2010 | 1599 | 0.060 |
Why?
|
Child Development | 1 | 2017 | 2327 | 0.060 |
Why?
|
Mexico | 2 | 2018 | 777 | 0.060 |
Why?
|
Protein Structure, Tertiary | 1 | 2012 | 3750 | 0.060 |
Why?
|
Enhancer Elements, Genetic | 1 | 2011 | 1365 | 0.060 |
Why?
|
Skin Diseases | 1 | 2013 | 1088 | 0.060 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 2627 | 0.060 |
Why?
|
Female | 18 | 2020 | 396112 | 0.060 |
Why?
|
Cell Line, Tumor | 2 | 2019 | 17075 | 0.060 |
Why?
|
Gene Regulatory Networks | 3 | 2017 | 1748 | 0.050 |
Why?
|
Interferon-gamma | 1 | 2012 | 3160 | 0.050 |
Why?
|
DNA Methylation | 1 | 2017 | 4424 | 0.050 |
Why?
|
Neuropsychological Tests | 1 | 2016 | 7123 | 0.050 |
Why?
|
Biological Specimen Banks | 2 | 2019 | 786 | 0.050 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 1 | 2022 | 26 | 0.050 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2012 | 2056 | 0.050 |
Why?
|
Genetic Variation | 1 | 2018 | 6610 | 0.050 |
Why?
|
Mice, Knockout | 1 | 2018 | 14448 | 0.050 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 6069 | 0.050 |
Why?
|
Air Pollutants | 1 | 2016 | 2923 | 0.050 |
Why?
|
Incineration | 1 | 2021 | 21 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2014 | 3655 | 0.050 |
Why?
|
Adult | 12 | 2020 | 223044 | 0.050 |
Why?
|
Construction Materials | 1 | 2021 | 60 | 0.050 |
Why?
|
Flow Cytometry | 1 | 2012 | 5881 | 0.050 |
Why?
|
Membrane Glycoproteins | 1 | 2011 | 3690 | 0.040 |
Why?
|
Base Sequence | 1 | 2012 | 12403 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2017 | 7851 | 0.040 |
Why?
|
Child, Preschool | 6 | 2020 | 42500 | 0.040 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2020 | 42 | 0.040 |
Why?
|
Protein Binding | 1 | 2012 | 9296 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2013 | 12240 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 6942 | 0.040 |
Why?
|
Linear Models | 2 | 2020 | 5876 | 0.040 |
Why?
|
Aerosols | 1 | 2021 | 633 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2011 | 4913 | 0.040 |
Why?
|
Nedocromil | 1 | 2018 | 45 | 0.040 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2022 | 669 | 0.040 |
Why?
|
HCT116 Cells | 1 | 2019 | 399 | 0.040 |
Why?
|
Volatilization | 1 | 2017 | 75 | 0.040 |
Why?
|
Proteins | 1 | 2012 | 5995 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2018 | 22223 | 0.030 |
Why?
|
Spheroids, Cellular | 1 | 2019 | 328 | 0.030 |
Why?
|
Macrophages | 1 | 2012 | 5772 | 0.030 |
Why?
|
Aging | 1 | 2016 | 8731 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 2017 | 368 | 0.030 |
Why?
|
Rheology | 1 | 2018 | 348 | 0.030 |
Why?
|
Immunoblotting | 1 | 2020 | 1644 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2020 | 1693 | 0.030 |
Why?
|
Bronchial Hyperreactivity | 1 | 2017 | 300 | 0.030 |
Why?
|
Models, Biological | 1 | 2012 | 9443 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2022 | 1394 | 0.030 |
Why?
|
Cell Size | 1 | 2017 | 625 | 0.030 |
Why?
|
Survival Analysis | 2 | 2019 | 10070 | 0.030 |
Why?
|
Motor Skills | 1 | 2018 | 516 | 0.030 |
Why?
|
Alleles | 2 | 2018 | 6897 | 0.030 |
Why?
|
Systems Biology | 1 | 2018 | 481 | 0.030 |
Why?
|
Phenotype | 3 | 2018 | 16721 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2020 | 12768 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2019 | 1237 | 0.030 |
Why?
|
Body Weights and Measures | 1 | 2013 | 208 | 0.030 |
Why?
|
Area Under Curve | 1 | 2017 | 1638 | 0.030 |
Why?
|
Mechanotransduction, Cellular | 1 | 2018 | 540 | 0.030 |
Why?
|
Nicotine | 1 | 2017 | 682 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2022 | 1759 | 0.020 |
Why?
|
Sp3 Transcription Factor | 1 | 2011 | 30 | 0.020 |
Why?
|
Netherlands | 1 | 2016 | 2277 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2017 | 2910 | 0.020 |
Why?
|
Particle Size | 1 | 2016 | 1631 | 0.020 |
Why?
|
Cohort Studies | 3 | 2020 | 41649 | 0.020 |
Why?
|
Nails | 1 | 2013 | 298 | 0.020 |
Why?
|
Biomarkers, Pharmacological | 1 | 2012 | 162 | 0.020 |
Why?
|
Demography | 1 | 2016 | 1641 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2011 | 295 | 0.020 |
Why?
|
Age Factors | 2 | 2020 | 18380 | 0.020 |
Why?
|
Genotype | 2 | 2018 | 13024 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2022 | 4348 | 0.020 |
Why?
|
Oxygen | 1 | 2022 | 4241 | 0.020 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2011 | 378 | 0.020 |
Why?
|
Collagen | 1 | 2019 | 2618 | 0.020 |
Why?
|
Fetal Blood | 1 | 2017 | 1369 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2019 | 6493 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2016 | 1751 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2020 | 65188 | 0.020 |
Why?
|
Public Health | 1 | 2022 | 2680 | 0.020 |
Why?
|
Weight Loss | 1 | 2019 | 2710 | 0.020 |
Why?
|
Mothers | 1 | 2018 | 2210 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2017 | 2741 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2016 | 1884 | 0.020 |
Why?
|
Airway Obstruction | 1 | 2012 | 665 | 0.020 |
Why?
|
Gene Expression | 1 | 2020 | 7584 | 0.020 |
Why?
|
Middle Aged | 6 | 2020 | 223009 | 0.020 |
Why?
|
Adolescent | 3 | 2022 | 88835 | 0.020 |
Why?
|
Smoking | 2 | 2013 | 9081 | 0.020 |
Why?
|
Aged | 5 | 2018 | 171117 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3946 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13266 | 0.020 |
Why?
|
Haplotypes | 1 | 2011 | 2728 | 0.020 |
Why?
|
Insulin | 1 | 2020 | 6599 | 0.020 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2017 | 2531 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2019 | 12437 | 0.010 |
Why?
|
Time Factors | 2 | 2016 | 40065 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5020 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2016 | 59489 | 0.010 |
Why?
|
Prognosis | 2 | 2017 | 29922 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2011 | 4618 | 0.010 |
Why?
|
Software | 1 | 2017 | 4462 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15880 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8733 | 0.010 |
Why?
|
Computer Simulation | 1 | 2016 | 6255 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2016 | 5343 | 0.010 |
Why?
|
Prospective Studies | 2 | 2017 | 54802 | 0.010 |
Why?
|
Body Mass Index | 1 | 2019 | 13039 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 22332 | 0.010 |
Why?
|
Young Adult | 2 | 2020 | 59889 | 0.010 |
Why?
|
Cytokines | 1 | 2016 | 7421 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2011 | 5786 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2016 | 14751 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18293 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2013 | 7838 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2017 | 20124 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39193 | 0.010 |
Why?
|
Risk Factors | 2 | 2016 | 74840 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2017 | 26346 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2012 | 8041 | 0.010 |
Why?
|
Pregnancy | 1 | 2017 | 30260 | 0.010 |
Why?
|
Infant | 1 | 2017 | 36386 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 24282 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2016 | 15652 | 0.010 |
Why?
|